Zymeworks Inc.
ZYME
$22.88
-$0.35-1.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.87% | 116.21% | 95.94% | 85.05% | 0.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.87% | 116.21% | 95.94% | 85.05% | 0.38% |
| Cost of Revenue | 0.37% | 14.57% | 18.60% | 7.18% | -4.43% |
| Gross Profit | 48.44% | 86.64% | 64.48% | 42.13% | 9.90% |
| SG&A Expenses | 0.01% | 3.53% | -2.03% | -9.51% | -12.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.26% | 10.98% | 11.52% | 1.38% | -7.16% |
| Operating Income | 23.95% | 42.41% | 32.00% | 26.96% | 11.33% |
| Income Before Tax | 31.61% | 52.50% | 41.86% | 16.18% | 2.21% |
| Income Tax Expenses | -77.38% | 269.10% | 280.20% | 445.46% | 1,171.13% |
| Earnings from Continuing Operations | 33.88% | 44.20% | 34.52% | 9.76% | -3.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.88% | 44.20% | 34.52% | 9.76% | -3.39% |
| EBIT | 23.95% | 42.41% | 32.00% | 26.96% | 11.33% |
| EBITDA | 24.95% | 46.85% | 35.57% | 28.73% | 11.07% |
| EPS Basic | 33.40% | 43.94% | 35.69% | 15.97% | 6.95% |
| Normalized Basic EPS | 20.61% | 45.22% | 34.43% | 33.76% | 22.97% |
| EPS Diluted | 33.24% | 43.72% | 35.72% | 16.08% | 7.22% |
| Normalized Diluted EPS | 20.54% | 45.19% | 34.41% | 33.79% | 23.00% |
| Average Basic Shares Outstanding | -0.59% | 0.46% | 2.48% | 6.13% | 10.16% |
| Average Diluted Shares Outstanding | 0.07% | 1.16% | 3.21% | 6.16% | 10.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |